Skip to main content
Infectious Diseases in Obstetrics and Gynecology logoLink to Infectious Diseases in Obstetrics and Gynecology
. 1994;2(3):140–145. doi: 10.1155/S1064744994000542

Propensity of Tampons and Barrier Contraceptives to Amplify Staphylococcus aureusToxic Shock Syndrome Toxin-I

Philip M Tierno Jr 1, Bruce A Hanna 1,
PMCID: PMC2364374  PMID: 18475381

Abstract

Objective: Although the incidence of reported cases of toxic shock syndrome (TSS) has declined in recent years, the disease continues to occur in menstruating women using the newer, less-absorbent tampons or barrier contraceptives. Extant tampons and other vaginal devices were tested for the ability to induce TSS toxin-1 (TSST-1) by a TSS strain of Staphylococcus aureus MN8, a known high-toxin producer. Tested for the first time were 20 varieties of tampons, including 2 all-cotton brands newly introduced in the United States, a polyurethane contraceptive sponge, a latex diaphragm, and a polymer menstrual collection cup.

Methods: All products were washed in sterile distilled water prior to use to reduce the effect of leachable chemicals. Duplicate experiments with unwashed products were also performed. Entire tampons and other test products were immersed in brain heart infusion broth plus yeast extract (BHIY) and inoculated with S. aureus MN8, a known TSST-1 producer. After incubation, the culture supernatants were assayed for TSST-1 by gel immunodiffusion.

Results: Except for all-cotton tampons, greater amounts of TSST-1 were detected in the supernatant fluid of washed tampons than detected in those which were not washed. While TSST-1 levels in unwashed non-cotton tampons ranged from 0.5 to 8 μg/ml, when these products were washed, TSST-1 levels increased to 2–32 μg/ml. In all-cotton tampons, whether washed or not, there was no detectable TSST-1.

Conclusions: The propensity for all-cotton tampons not to amplify TSST-1 in vitro suggests they would lower the risk for tampon-associated TSS.

Full Text

The Full Text of this article is available as a PDF (436.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen S. T., Liland J. B., Nichols C. G., Glew R. H. Toxic shock syndrome associated with use of latex nasal packing. Arch Intern Med. 1990 Dec;150(12):2587–2588. [PubMed] [Google Scholar]
  2. Baehler E. A., Dillon W. P., Dryja D. M., Neter E. The effects of prolonged retention of diaphragms on colonization by Staphylococcus aureus of the lower genital tract. Fertil Steril. 1983 Feb;39(2):162–166. doi: 10.1016/s0015-0282(16)46813-5. [DOI] [PubMed] [Google Scholar]
  3. Centers for Disease Control (CDC) Reduced incidence of menstrual toxic-shock syndrome--United States, 1980-1990. MMWR Morb Mortal Wkly Rep. 1990 Jun 29;39(25):421–423. [PubMed] [Google Scholar]
  4. Given W. D. Toxic shock syndrome associated with diaphragm use. W V Med J. 1986 Jun;82(6):171–173. [PubMed] [Google Scholar]
  5. Holland K. T., Ingham E., Eady E. A., Gowland G. Toxic shock syndrome: the effect of solid phase materials on the physiology of Staphylococcus aureus. Postgrad Med J. 1985;61 (Suppl 1):39–43. [PubMed] [Google Scholar]
  6. Leads from the MMWR. Toxic-shock syndrome and the vaginal contraceptive sponge. JAMA. 1984 Feb 24;251(8):1015–1016. [PubMed] [Google Scholar]
  7. Lee A. C., Crass B. A., Bergdoll M. S. Investigation by syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus. J Clin Microbiol. 1987 Jan;25(1):87–90. doi: 10.1128/jcm.25.1.87-90.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Reiser R. F., Hinzman S. J., Bergdoll M. S. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus restricted to endogenous air in tampons. J Clin Microbiol. 1987 Aug;25(8):1450–1452. doi: 10.1128/jcm.25.8.1450-1452.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Robbins R. N., Reiser R. F., Hehl G. L., Bergdoll M. S. Production of toxic shock syndrome toxin 1 by Staphylococcus aureus as determined by tampon disk-membrane-agar method. J Clin Microbiol. 1987 Aug;25(8):1446–1449. doi: 10.1128/jcm.25.8.1446-1449.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Schlievert P. M., Deringer J. R., Kim M. H., Projan S. J., Novick R. P. Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob Agents Chemother. 1992 Mar;36(3):626–631. doi: 10.1128/aac.36.3.626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Tierno P. M., Jr, Hanna B. A. In vitro amplification of toxic shock syndrome toxin-1 by intravaginal devices. Contraception. 1985 Feb;31(2):185–194. doi: 10.1016/0010-7824(85)90033-2. [DOI] [PubMed] [Google Scholar]

Articles from Infectious Diseases in Obstetrics and Gynecology are provided here courtesy of Wiley

RESOURCES